Literatur
-
1
Anderson K M, Castelli W P, Levy D.
Cholesterol and mortality: 30 years of follow-up from the
Framingham
study.
JAMA.
1987;
257
2176-2180
-
2
Arbogast A, Sechtem U.
Diagnose der Herzkrankheit bei Frauen.
Dtsch Med
Wochenschr.
2003;
128
97-102
-
3
Bankier B, Littman A B.
Psychiatric disorders and coronary heart disease in women
- a still neglected topic: review of the literature from 1971 to
2000.
Psychother
Psychosom.
2002;
71
133-140
-
4
Castelli W P.
Epidemiology of triglycerides: a view from
Framingham.
Am J
Cardiol.
1992;
70
3H-9H
-
5
Christen W G, Ajani U A, Glynn R J, Hennekens C H.
Blood levels of homocysteine and increased risk of
cardiovascular disease: causal or casual.
Arch Intern
Med.
2000;
160
422-434
-
6
Corti M C, Guralnik J M, Salive M E. et al .
HDL cholesterol predicts coronary heart disease mortality in
older
persons.
JAMA.
1995;
274
539-544
-
7
Dierkes J, Jeckel A, Ambrosch A, Westphal S, Luley C, Boeing H.
Factors explaining the difference of total homocyst(e)ine
between men and women in the European Investigation into Cancer and Nutrition
Potsdam
Study.
Metabolism.
2001;
50
640-645
-
8
Dorn J M, Schisterman E F, Winkelstein W, Trevisan M.
Body mass index and mortality in a general population sample
of men and women. The Buffalo Health Study.
Am J
Epidemiol.
1997;
146
919-931
-
9
Eaker E D.
Psychosocial risk factors for coronary heart disease in
women.
Cardiol
Clin.
1998;
16
103-111
-
10
Eriksson M, Egberg N, Wamala S, Orth-Gomer K, Mittleman M A, Schenck-Gustafsson K.
Relationship between plasma fibrinogen and coronary heart
disease in women.
Arterioscler Thromb Vasc
Biol.
1999;
19
67-72
-
11
Folsom A R, Kushi L H, Anderson K E. et al .
Association of general and abdominal obesity with multiple
health outcomes in older women: the Iowa Women’s Health
Study.
Arch Intern
Med.
2000;
160
2117-2128
-
12
Folsom A R, Nieto F J, McGovern P G. et al .
Prospective study of coronary heart disease incidence in
relation to fasting total homocysteine, related genetic polymorphisms, and B
vitamines: the Atherosclerosis Risk in Communities (ARIC)
study.
Circulation.
1998;
98
204-210
-
13
Folsom A R, Wu K K, Rasmussen M, Chambless L E, Aleksic N, Nieto F J.
Determinants of population changes in fibrinogen and factor
VII over 6 years. The Atherosclerosis Risk in Communities (ARIC)
Study.
Arterioscler Thromb Vasc
Biol.
2000;
20
601-606
-
14
Folsom A R, Wu K K, Rosamond W D, Sharrett A R, Chambless L E.
Prospective study of hemostatic factors and incidence of
coronary heart disease: the Atherosclerosis Risk in Communities (ARIC)
Study.
Circulation.
1997;
96
1102-1108
-
15
Friedlander Y, Arbogast P, Schwartz S M. et al .
Family history as a risk factor for early onset myocardial
infarction in young
women.
Atherosclerosis.
2001;
156
201-207
-
16
Garber A M, Browner W S, Hulley S B.
Cholesterol screening in asymptomatic adults,
revisited.
Ann Intern
Med.
1996;
124
518-531
-
17
Gohlke-Bärwolf C.
Coronary artery disease - is menopause a risk
factor?.
Basic Res
Cardiol.
2000;
95
I/77-I/83
-
18
Gordon D J, Probstfield J L, Garrison R J. et al .
High-density lipoprotein cholesterol and cardiovascular
disease: four prospective American
studies.
Circulation.
1989;
79
8-15
-
19
Grady D, Herrington D, Bittner V. et al. HERS Research Group .
Cardiovascular disease outcomes during 6.8 years of hormone
therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS
II).
JAMA.
2002;
288
49-57
-
20
Hahmann H W, Schätzer-Klotz D, Bunte T, Becker D, Schieffer H J.
The significance of high levels of lipoprotein (a) compared
with established risk factors in premature coronary artery disease: differences
between men and
women.
Atherosclerosis.
1999;
144
221-228
-
21
Haynes S G, Feinleib M, Kannel W B.
The relationship of psychosocial factors to coronary heart
disease in the Framingham Study. III. Eight-year incidence of coronary heart
disease.
Am J
Epidemiol.
1980;
111
37-58
-
22
Hokanson J E, Austin M A.
Plasma triglyceride level is a risk factor for cardiovascular
disease independent of high-density lipoprotein cholesterol level: a
meta-analysis of population-based prospective studies.
J Cardiovasc
Risk.
1996;
3
213-219
-
23
Hu F B, Stampfer M J, Manson J E. et al .
Trends in the incidence of coronary heart disease and changes
in diet and lifestyle in women.
N Engl J
Med.
2000;
343
530-537
-
24
Hu F B, Stampfer M J, Solomon C. et al .
Physical activity and risk for cardiovascular events in
diabetic women.
Ann Intern
Med.
2001;
134
96-105
-
25
Kannel W B.
Risk stratification in hypertension: new insights from the
Framingham Study.
Am J
Hypertens.
2000;
13
3S-10S
-
26
Kuulasmaa K, Tunstall-Pedoe H, Dobson A. et al., for the MONICA Project .
Estimation of contribution of changes in classic risk factors
to trends in coronary event-rates across the WHO MONICA Project
populations.
Lancet.
2000;
355
675-687
-
27
Laakso M, Ronnemaa T, Lehto S, Puukka P, Kallio V, Pyorala K.
Does NIDDM increase the risk for coronary heart disease
similarly in both low- and high-risk
populations?.
Diabetologia.
1995;
38
487-493
-
28
Laing S P, Swerdlow A J, Slater S D. et al .
The British Diabetic Association Cohort Study, II:
cause-specific mortality in patients with insulin-treated diabetes
mellitus.
Diabet
Med.
1999;
16
466-471
-
29
Lapidus L, Bengtsson C, Lindquist O, Sigurdsson J A, Ryboe E.
Triglycerides - main lipid risk factor for
cardiovascular disease in women?.
Acta Med
Scand.
1985;
217
481-489
-
30
Lee I M, Rexrode K M, Cook N R, Manson J E, Buring J E.
Physical activity and coronary heart disease in women: Is
„no pain, no gain“
passé?.
JAMA.
2001;
285
1447-1454
-
31
Lee W L, Cheung A M, Cape D, Zinman B.
Impact of diabetes on coronary artery disease in women and
men: a meta-analysis of prospective studies.
Diabetes
Care.
2000;
23
962-968
-
32
Manolio T A, Pearson T A, Wenger N K, Barrett-Connor E, Payne G H, Harlan W R.
Cholesterol and heart disease in older persons and women:
review of an NHLBI workshop.
Ann
Epidemiol.
1992;
2
161-176
-
33
Mansfield M W, Heywood D M, Grant P J.
Sex differences in coagulation and fibrinolysis in white
subjects with non-insulin-dependent diabetes mellitus.
Arterioscler
Thromb Vasc
Res.
1996;
16
160-164
-
34
Manson J AE, Hu F B, Rich-Edwards J W. et al .
A prospective study of walking as compared with vigorous
exercise in the prevention of coronary heart disease in women.
N Engl
J
Med.
1999;
341
650-658
-
35
Maron D J.
The epidemiology of low levels of high-density lipoprotein
cholesterol in patients with and without coronary artery disease.
Am
J
Cardiol.
2000;
86
11L-14L
-
36
Meade T W, Ruddock V, Stirling Y, Chakrabarti R, Miller G J.
Fibrinolytic activity, clotting factors, and long-term
incidence of ischaemic heart disease in the Northwick Park Heart
Study.
Lancet.
1993;
342
1076-1079
-
37
Nanchahal K, Ashton W D, Wood D A.
Association between blood pressure, the treatment of
hypertension, and cardiovascular risk factors in women.
J
Hypertens.
2000;
18
833-841
-
38
Orth-Gomer K, Horsten M, Wamala S P. et al .
Social relations and extent and severity of coronary artery
disease: The Stockholm Female Coronary Risk Study.
Eur Heart
J.
1998;
19
1648-1656
-
39
Orth-Gomer K, Mittleman M A, Schenck-Gustafsson K. et al .
Lipoprotein (a) as a determinant of coronary heart disease in
young
women.
Circulation.
1997;
95
329-334
-
40
Orth-Gomer K, Wamala S P, Horsten M, Schenck-Gustafsson K, Schneiderman N, Mittleman M A.
Marital stress worsens prognosis in women with coronary heart
disease: The Stockholm Female Coronary Risk
Study.
JAMA.
2000;
284
3008-3014
-
41
Ossei-Gerning N, Wilson I J, Grant P J.
Sex differences in coagulation and fibrinolysis in subjects
with coronary artery disease.
Thromb
Haemost.
1998;
79
736-740
-
42
Poulter R. for the WHO Collaborative Study of Cardiovascular Disease
and Steroid Hormone Contraception .
Acute myocardial infarction and combined oral contraceptives:
results of an international multicentre case-control
study.
Lancet.
1997;
349
1202-1209
-
43
Ridker P M, Buring J E, Shih H, Matias M, Hennekens C H.
Prospective study of C-reactive protein and the risk of
future cardiovascular events among apparently healthy
women.
Circulation.
1998;
98
731-733
-
44
Ridker P M, Hennekens C H, Buring J E, Rifai N.
C-reactive protein and other markers of inflammation in the
prediction of cardiovascular disease in women.
N Engl J
Med.
2000;
342
836-843
-
45
Ridker P M, Manson J E, Buring J E, Shih J, Matias M, Hennekens C H.
Homocyst(e)ine and risk of cardiovascular disease among
postmenopausal
women.
JAMA.
1999;
281
1817-1821
-
46
Rossouw J E, Anderson G L, Prentice R L. et al. Writing Group for the Women’s Health
Initiative Investigators .
Risks and benefits of estrogen plus progestin in healthy
postmenopausal women: principal results From the Women’s Health
Initiative randomized controlled
trial.
JAMA.
2002;
288
321-333
-
47
Rozanski A, Blumenthal J A, Kaplan J.
Impact of psychological factors on the pathogenesis of
cardiovascular disease and implication for
therapy.
Circulation.
1999;
99
2192-2217
-
48
Schulte H, von Eckardstein A, Cullen P, Assmann G.
Obesity and cardiovascular
risk.
Herz.
2001;
26
170-177
-
49
Sesso H D, Lee I M, Gaziano J M, Rexrode K M, Glynn R J, Buring J E.
Maternal and paternal history of myocardial infarction and
risk of cardiovascular disease in men and
women.
Circulation.
2001;
104
393-398
-
50
Stampfer M J, Hu F B, Manson J E, Rimm E B, Willett W C.
Primary prevention of coronary heart disease in women through
diet and lifestyle.
N Engl J
Med.
2000;
343
16-22
-
51
Stangl V, Baumann G, Stangl K.
Coronary atherogenic risk factors in women.
Eur
Heart
J.
2002;
23
1738-1752
-
52
The writing group for the PEPI Trial .
Effects of estrogen or estrogen/progestin regimens on
heart disease risk factors in postmenopausal women: the Postmenopausal
Estrogen/Progestin Interventions (PEPI)
trial.
JAMA.
1995;
273
199-208
-
53
Verhoef P.
Hyperhomocysteinemia and risk of vascular disease in
women.
Semin Thromb
Hemost.
2000;
26
325-334
-
54
Wagenknecht L E, Craven T E, Preisser J S, Manolio T A, Winders S, Hulley S B.
Ten-year trends in cigarette smoking among young adults,
1986 - 1996: The CARDIA Study.
Ann
Epidemiol.
1998;
8
301-307
-
55
Wamala S P, Mittleman M A, Horsten M, Schenck-Gustafsson K, Orth-Gomer K.
Job stress and the occupational gradient in coronary heart
disease in women: The Stockholm Female Coronary Risk Study.
Soc Sci
Med.
2000;
51
481-489
-
56
Welch G N, Loscalzo J.
Homocysteine and atherothrombosis.
N Engl J
Med.
1998;
338
1042-1050
-
57
Welty F K.
Cardiovascular disease and dsylipidemia in
women.
Arch Intern
Med.
2001;
161
514-522
-
58
Willett W C, Manson J E, Stampfer M J. et al .
Weight, weight change, and coronary heart disease in
women.
JAMA.
1995;
273
461-465
-
59
Woodward M, Lowe G DO, Rumley A, Tunstall-Pedoe H.
Fibrinogen as a risk factor for coronary heart disease and
mortality in middle-aged men and women.
Eur Heart
J.
1998;
19
55-62
Priv.-Doz. Dr. med. Verena Stangl
Charité der Humboldt-Universität. Campus Mitte, Med.
Klinik mit Schwerpunkt Kardiologie, Angiologie, Pneumologie
Schumannstraße 21/21
10117 Berlin
Telefon: +49/030/450513153
Fax: +49/030/450513932
eMail: verena.stangl@charite.de
